Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Analyst Coverage
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
Feb 27, 2019 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-19-004643.pdf
0001564590-19-004643.rtf
0001564590-19-004643.xls
Mar 12, 2019 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-19-007251.pdf
0001564590-19-007251.rtf
0001564590-19-007251.xls
Mar 25, 2019 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-19-009079.pdf
0001564590-19-009079.rtf
0001564590-19-009079.xls
Apr 02, 2019 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-19-010478.pdf
0001564590-19-010478.rtf
0001564590-19-010478.xls
Apr 29, 2019 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
View HTML
0001564590-19-013503.pdf
0001564590-19-013503.rtf
0001564590-19-013503.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Apr 30, 2019 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-19-013940.pdf
0001564590-19-013940.rtf
0001564590-19-013940.xls
May 17, 2019 DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Registration Statements
View HTML
0000950123-19-005595.pdf
0000950123-19-005595.rtf
0000950123-19-005595.xls
May 31, 2019 F-1

Registration statement for certain foreign private issuers

Registration Statements
View HTML
0001193125-19-161584.pdf
0001193125-19-161584.rtf
0001193125-19-161584.xls
Jun 10, 2019 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0000950123-19-005902.pdf
0000950123-19-005902.rtf
0000950123-19-005902.xls
Jun 17, 2019 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001193125-19-174310.pdf
0001193125-19-174310.rtf
0001193125-19-174310.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Footer Social Icons

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
3 Temasek Avenue, Level 18,
Singapore 039190
Tel: +65 6817 9598

contact@aslanpharma.com